Annual Long Term Debt
$0.00
-$408.00 K-100.00%
31 December 2023
Summary:
Day One Biopharmaceuticals annual long term debt is currently $0.00, with the most recent change of -$408.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$204.00 thousand (-100.00%). DAWN annual long term debt is now -100.00% below its all-time high of $408.00 thousand, reached on 31 December 2022.DAWN Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$2.54 M
0.00%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly long term debt is currently $2.54 millionOver the past year, it has increased by +$2.46 million (+3196.10%). DAWN quarterly long term debt is now at all-time high.DAWN Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -100.0% | +3196.1% |
3 y3 years | -100.0% | +3804.6% |
5 y5 years | - | - |
DAWN Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -100.0% | at high | ||
5 y | 5 years | -100.0% | at high | ||
alltime | all time | -100.0% | at high |
Day One Biopharmaceuticals Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $2.54 M(>+9900.0%) |
Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2023 | - | $77.00 K(-59.5%) |
June 2023 | - | $190.00 K(-36.7%) |
Mar 2023 | - | $300.00 K(-26.5%) |
Dec 2022 | $408.00 K | $408.00 K(-20.6%) |
Sept 2022 | - | $514.00 K(-16.7%) |
Date | Annual | Quarterly |
---|---|---|
June 2022 | - | $617.00 K(>+9900.0%) |
Mar 2022 | - | $0.00(-100.0%) |
Dec 2021 | $16.00 K(-92.2%) | $16.00 K(-75.4%) |
Sept 2021 | - | $65.00 K(-42.0%) |
June 2021 | - | $112.00 K(-29.6%) |
Mar 2021 | - | $159.00 K(-22.1%) |
Dec 2020 | $204.00 K(>+9900.0%) | $204.00 K |
Dec 2019 | $0.00 | - |
FAQ
- What is Day One Biopharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual long term debt year-on-year change?
- What is Day One Biopharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly long term debt year-on-year change?
What is Day One Biopharmaceuticals annual long term debt?
The current annual long term debt of DAWN is $0.00
What is the all time high annual long term debt for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual long term debt is $408.00 K
What is Day One Biopharmaceuticals annual long term debt year-on-year change?
Over the past year, DAWN annual long term debt has changed by -$408.00 K (-100.00%)
What is Day One Biopharmaceuticals quarterly long term debt?
The current quarterly long term debt of DAWN is $2.54 M
What is the all time high quarterly long term debt for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly long term debt is $2.54 M
What is Day One Biopharmaceuticals quarterly long term debt year-on-year change?
Over the past year, DAWN quarterly long term debt has changed by +$2.46 M (+3196.10%)